Found: 3
Select item for more details and to access through your institution.
A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 4, p. 738, doi. 10.1007/s10637-019-00768-6
- By:
- Publication type:
- Article
Extended Antitumor Responseof a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib.
- Published in:
- Case Reports in Oncology, 2014, v. 7, n. 2, p. 343, doi. 10.1159/000363377
- By:
- Publication type:
- Article
A review of the incidence of tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with venetoclax and debulking strategies.
- Published in:
- EJHaem, 2022, v. 3, n. 2, p. 492, doi. 10.1002/jha2.427
- By:
- Publication type:
- Article